Impaired relaxation in aorta from streptozotocin-diabetic rats: Effect of aminoguanidine (AMNG) treatment

Experimental Diabesity Research

Volumn 1, Issue 2, 2000, Pages 145-153

  Özyazgan, Sibel ^a   Unlucerci, Yesim ^a   Bekpinar, Selda ^a   Akkan, Ahmet GÖkhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Aorta; Diabetes; Endothelium; Streptozotocin

Indexed keywords

ACETYLCHOLINE; AMINOGUANIDINE; GUANIDINE DERIVATIVE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REFERENCE VALUE; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; GUANIDINES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; NOREPINEPHRINE; RATS; RATS, WISTAR; REFERENCE VALUES; VASOCONSTRICTION; VASODILATION;

EID: 0034574492     PISSN: 15438600     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/EDR.2000.145     Document Type: Article

References (58)

1. The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977-986.
2. Semenkovich, C. F. and Heinecke, J. N. (1997). The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes, 46, 327-334.
3. DeRubertis, F. R. and Craven, P. A. (1994). Activation protein kinase C in glomerular cells in diabetes: mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes, 43, 1-8.
4. King, G. L., Shiba, T., Oliver, J., Inoguchi, T. and Bursell, S. E. (1994). Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Ann. Rev. Med., 45, 179-188.
5. Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengoard, J. R., van den Ender, M., Kilo, C. and Tilton, R. G. (1993). Hyperglycaemic pseudohypoxia and diabetic complications. Diabetes, 42, 801-813.
6. Bucala, R., Makita, Z., Koschinsky, T., Cerami, A. and Ulassara, H. (1993). Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Watl, Acad. Sci. USA, 90, 6434-6438.
7. Vlassara, H., Bucala, R. and Striker, L. (1994). Pathogenic effects of AGE's: biochemical, biological and clinical implications for diabetes and ageing. Lab. Invest., 70, 138-151.
8. Brownlee, M., Cerami, A. and Vlassara, H. (1998). Advanced glycosylation and products in tissue and the biochemical basis of complications. N. Engl. J. Med., 318, 1315-1321.
9. Hammes, H. P., Federoff, H. J. and Brownlee, M. (1995). Nerve growth factor prevents neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med., 1, 527-534.
10. Agrawal, D. K. and Mc Weill, J. H. (1987). Vascular responses to agonist in rat mesenteric artery from diabetic rats. Can. J. Physiol. Pharmacol., 65, 1484-90.
11. Takiguchi, Y., Saton, N., Hashimoto, H. and Nakashima, M. (1989). Reversal effect of thyroxine on altered vascular reactivity in diabetic rats. J. Cardiovasc. Pharmacol., 13, 520-524.
12. White, R. F. and Carrier, G. O. (1990). Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin- diabetes. J. Pharmacol Exp. Ther., 253, 1057-1062.
13. Cameron, N. E. and Catter, M. A. (1992). Impaired contraction and relaxation in aorta from streptozotocin diabetic rats: role of polyol pathway. Diabetologia, 35, 1011-1019.
14. Taylor, P. D., Mc Carthy, A. L., Thmas, C. R. and Poston, L. (1992). Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br. J. Pharmacol., 107, 393-9.
15. Yagihashi, S., Kamijo, M., Baba, M., Yagihashi, N. and Nagai, K. (1992). Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes, 41, 47-52.
16. Bucala, R., Cerami, A. and Vlassara, H. (1995). Advanced glycosylation end product in diabetic complications. Diabetes Rev., 3, 258-268.
17. Griffiths, M. J., Messent, M., Mac Allister, R. J. and Evans, T. W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110(3), 963-968.
18. Giardino, I. F., Arman, K., Hatechell, D. L. and Browniee, M. (1998). Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation and oxidant-induced apoptosis. Diabetes, 47(7), 1114-1120.
19. Kamata, K., Miyata, N. and Kasuya, Y. (1989). Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin induced diabetes rats. Br. J. Pharmacol., 97(2), 614-618.
20. Heygate, K. M., Lawrence, I. G., Bennett, M. A. and Thurston, H. (1995). Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br. J. Pharmacol., 116(8), 3251-3259.
21. Dieper, G. M. and Gross, G. J. (1989). Selective impairment of endothelium-dependent relaxation by oxygen-derived free radicals: distinction between receptor versus non receptor mediator. Blood Vessels, 26, 44-47.
22. Agrobast, B. W., Berry, D. L. and Newell, C. L. (1984). Injury of arterial endothelial cells in diabetic. Sucrose fed and aged rats. Atherosclerosis, 51, 31-45.
23. Hattori, Y., Kawasaki, H., Abe, K. and Kanno, M. (1991). Superoxide dismutase recovers altered endothelium dependent relaxation in diabetic rat aorta. Am. J. Physiol., 261, H1086-H1094.
24. Öztürk, M., Tunçdemir, M., Bolkent, S., Kaya, S., Yilmazer, S., Akkan, A. G., Ozyazgan, S., Senses, V. and Özüner, Z. (1997). An ultrastructural study on the effects of AICA-riboside treatment on aortic alteration in neonatal STZ-induced diabetic rats. 13th. National Electron Microscopy Congress Proceedings, Ankara, pp. 335-340.
25. Oyama, Y., Kawasaki, H., Hattori, Y. and Kanno, M. (1986). Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol., 131, 75-78.
26. Durante, W., Sen, A. K. and Sunahara, F. A. (1988). Impairment of endothelium-dependent relaxation in aorta from spontaneously diabetic rats. Br. J. Pharmacol., 94, 463-468.
27. Tesfamariam, B. and Cohen, R. A. (1992). Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol., 263, H321-H326.
28. Fiol de Cuneo, M., Ruiz, R. D., Lacnara, J. L. and Santillan de Tores, R. (1988). Contractility and pharmacological reactivity of isolated vascular smooth muscle from diabetic rats. Pharmacology, 36(4), 228-237.
29. Agrawal, D. K., Bhimji, S. and McNeil, J. H. (1987b). Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J. Cardiovasc. Pharmacol., 9(5), 584-593.
30. Furchgott, R. F. and Zawadzki, J. V. (1980). The obligatory role of endothelial cells in the relaxation of smooth muscle cells by acetylcholine. Nature, 288, 373-376.
31. Palmer, R. M. J., Ferrige, A. G. and Moncada, S. (1987). Nitric oxide account the biological activity of endothelium-derived relaxing factors. Nature, 327, 524-526.
32. Ceriello, A., Quatraro, A. and Guigliano, D. (1979). Diabetes Mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia, 17, 371-377.
33. Young, I. S., Tate, S., Lightbody, J. H., Mcmaster, D. and Trimble, E. R. (1995). The effect of desferoxamine and ascorbate on oxidative stress in the streptozotocin diabetic rats. Free Radic. Biol. Med., 18, 833-840.
34. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P. and Cerami, A. (1986). Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science (Wash. DC), 232, 1629-1632.
35. Bucala, R., Tracey, K. J., Cerami, A. (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Ýnvest., 87, 432-438.
36. Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y. and Yamamoto, H. (1998). Advanced glycation and products inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia, 41, 1425-1441.
37. Dewhurst, M., Stevens, E. J., Karasu, C. and Tomlinson, D. R. (1994). Effects of aminoguanidine treatment on sciatic nerve laser Doppler flux and prostacyclin release from vasculer tissues and sciatic nerve of control and streptozotocin diabetic rats. Br. J. Pharmacol., 112, 373.
38. Huijberts, M. S. P., Wolffenbuttel, B. H. R., Boudier, H. A. J. S., Crijns, F. R. L., Kruseman, A. C. N., Poitevin, P. and Levy, B. I. (1993). Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest., 92, 1407-1411.
39. Kumari, K., Uman, S., Bansal, V., Sahib, M. K. (1991a). Mono aminoguanidine inhibits aldose reductase. Biochem. Pharmacol., 15; 41(10), 1527-1528.
40. Kumari, K., Uman, S., Bansal, V. and Sahib, M. K. (1991b). Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes, 40(8), 1079-84.
41. Taylor, P. D., Graves, J. E. and Poston, L. (1995). Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of the streptozotocin-induced diabetic-rat. Clin. Sci., 88, 519-524.
42. Kiff, R. J., Gardiner, S. M., Comptom, A. M. and Bennett, T. (1991). Selective impairment of hindquarter vasodilator responses to bradykinin in conscious Wistar rats with STZ-induced diabetes mellitus. Br. J. Pharmacol., 103, 1357-1362.
43. ++-free medium. Eur. J. Pharmacol., 256(2), 215-219.
44. Rembold, C. M. (1992). Regulation of contraction and relaxation in arterial smooth muscle. Hypertension, 20, 129-137.
45. Crijns, F. R. L., Boudier, S. H. A. J. and Wolffenbuttel, B. H. R. (1998). Arteriolar reactivity in conscious diabetic rats: Influence of aminoguanidine treatment. Diabetes, 47, 918-923.
46. Archibald, V., Cotter, M. A., Keegan, A. and Cameron, N. E. (1996). Contraction and relaxation of aortas from diabetic rats: Effects of chronic anti-oxidant and aminoguanidine treatment. Naunyn-Schmiedebergs-Arch-Pharmacol., 353(5), 584-91.
47. Bohr, D. F. (1963). Vascular smooth muscle. Dual effects of calcium. Science, 139, 597-599.
48. Scarborough, N. L. and Carrier, G. O. (1984a). Nifedipine and alpha adrenoceptors in rat aorta: I. Role of extracellular calcium in alpha-1 and alpha-2 adrenoceptor-mediated contraction. J. Pharmacol. Exp. Ther., 231, 597-602.
49. Scarborough, N. L. and Carrier, G. O. (1984b). Nifedipine and alpha adrenoceptors in rat aorta: II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction. J. Pharmacol. Exp. Ther., 231, 603-609.
50. Mc Leod, K. M. and Mc Neill, J. H. (1982). Alpha adrenoceptor mediated responses in aorta from three month streptozotocin-diabetic rats. Proc. West. Pharmacol. Soc., 25, 245-247.
51. Sullivan, S. and Spark, H. V. (1979). Diminished contractile response of aortas from diabetic rabbits. Am. J. Physiol., 236, 301-306.
52. Fortes, Z. B., Lerne, J. G. and Scivoletto, R. (1983). Vascular reactivity in diabetes mellitus. Role of the endothelial cell. Br. J. Pharmacol., 79, 771-781.
53. Özyazgan, S., Senses, V., Ince, E., Sultuybek, G., Utkan, T. and Akkan, A. G. (1998). The effect of succinic acid monomethyl ester (SAM) on the responses of isolated thoracic aorta in streptozotocin-diabetic rats. Pharmacol. Res., 38(1), 73-79.
54. Mulherm, M. and Docherty, R. J. (1989). Effect of experimental diabetes on the responsiveness of rat aorta. Br. J. Pharmacol., 97, 1007-1012.
55. Harris, K. H. and Mc Leod, K. M. (1988). Influence of endothelium on contractile responses of arteries from diabetic rats. Eur. J. Pharmacol., 153(1), 55-6.
56. Owen, M. P. and Carrier, G. O. (1979). Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin-induced diabetes. Proc. West Pharmacol. Soc., 22, 363-366.
57. Ramanadham, S., Lyness, W. H. and Tenner, T. E. (1984). Alteration in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can. J. Physiol. Pharmacol., 62(4), 418-23.
58. 2 mobilisation in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice. Br. J. Pharmacol., 123, 1509-1516.